Bucheon, South Korea · Founded 2017 · Privately Held (backing)
Operator of a biomedical company intended to make botulinum toxin. Inibio is based in Bucheon, South Korea and was founded in 2017. Its last reported valuation was $129 million in Feb 2025.
These 2 firms already write checks for companies like Inibio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
